Review

. 2014 Nov 4:5:189.

doi: 10.3389/fendo.2014.00189. eCollection 2014.

Aspartate aminotransferase - risk marker for type-2 diabetes mellitus or red herring?

Setor K Kunutsor¹, Ali Abbasi², Tanefa A Apekey³

Affiliations

¹ Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge , Cambridge , UK.
² MRC Epidemiology Unit, Institute of Metabolic Science, Cambridge Biomedical Campus, University of Cambridge School of Clinical Medicine , Cambridge , UK ; Department of Epidemiology, University Medical Center Groningen, University of Groningen , Groningen , Netherlands ; Department of Internal Medicine, University Medical Center Groningen, University of Groningen , Groningen , Netherlands.
³ Sport, Health and Nutrition Department, Leeds Trinity University , Leeds , UK.

PMID: 25408682
PMCID: PMC4219379
DOI: 10.3389/fendo.2014.00189

Review

Aspartate aminotransferase - risk marker for type-2 diabetes mellitus or red herring?

Setor K Kunutsor et al. Front Endocrinol (Lausanne). 2014.

. 2014 Nov 4:5:189.

doi: 10.3389/fendo.2014.00189. eCollection 2014.

Authors

Setor K Kunutsor¹, Ali Abbasi², Tanefa A Apekey³

Affiliations

¹ Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge , Cambridge , UK.
² MRC Epidemiology Unit, Institute of Metabolic Science, Cambridge Biomedical Campus, University of Cambridge School of Clinical Medicine , Cambridge , UK ; Department of Epidemiology, University Medical Center Groningen, University of Groningen , Groningen , Netherlands ; Department of Internal Medicine, University Medical Center Groningen, University of Groningen , Groningen , Netherlands.
³ Sport, Health and Nutrition Department, Leeds Trinity University , Leeds , UK.

PMID: 25408682
PMCID: PMC4219379
DOI: 10.3389/fendo.2014.00189

No abstract available

Keywords: aspartate aminotransferase; liver enzymes; meta-analysis; risk factors; type-2 diabetes mellitus.

PubMed Disclaimer

Figures

**Figure 1**
**Prospective studies of aspartate aminotransferase levels and type-2 diabetes mellitus risk, grouped according to covariate adjustment levels**. The summary estimates presented were calculated using random-effects models; degree of adjustment: +, adjusted for age and/sex; ++, additionally adjusted for diabetes risk factors; +++, further adjusted for other liver enzymes; AST, aspartate aminotransferase; bars, 95% CI; RR, relative risk.

See this image and copyright information in PMC

Cited by

An ensemble-based machine learning model for predicting type 2 diabetes and its effect on bone health.
Alsadi B, Musleh S, Al-Absi HRH, Refaee M, Qureshi R, El Hajj N, Alam T. Alsadi B, et al. BMC Med Inform Decis Mak. 2024 May 29;24(1):144. doi: 10.1186/s12911-024-02540-0. BMC Med Inform Decis Mak. 2024. PMID: 38811939 Free PMC article.
Association between liver enzymes and type 2 diabetes: a real-world study.
Bi Y, Yang Y, Yuan X, Wang J, Wang T, Liu Z, Tian S, Sun C. Bi Y, et al. Front Endocrinol (Lausanne). 2024 Feb 20;15:1340604. doi: 10.3389/fendo.2024.1340604. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38444589 Free PMC article.
Antidiabetic effects of Eryngium billardieri hydrosol in the treatment of type 2 diabetic patients: A double-blind randomized clinical trial.
Hamami Chamgordani Z, Mazaheri M, Iraj B, Baghshahi H, Sabouhi F. Hamami Chamgordani Z, et al. Avicenna J Phytomed. 2023 Jan-Feb;13(1):34-44. doi: 10.22038/AJP.2022.21175. Avicenna J Phytomed. 2023. PMID: 36698734 Free PMC article.
Association of mean arterial pressure with 5-year risk of incident diabetes in Chinese adults：a secondary population-based cohort study.
Wu Y, Hu H, Cai J, Chen R, Zuo X, Cheng H, Yan D. Wu Y, et al. BMJ Open. 2022 Sep 19;12(9):e048194. doi: 10.1136/bmjopen-2020-048194. BMJ Open. 2022. PMID: 36123108 Free PMC article.
CTNNA3 genetic polymorphism may be a new genetic signal of type 2 diabetes in the Chinese Han population: a case control study.
Zhang Y, Zhou X, Dai W, Sun J, Lin M, Zhang Y, Ding Y. Zhang Y, et al. BMC Med Genomics. 2021 Oct 30;14(1):257. doi: 10.1186/s12920-021-01105-8. BMC Med Genomics. 2021. PMID: 34717601 Free PMC article.

See all "Cited by" articles

References

1. Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ (2005) 172:367–79.10.1503/cmaj.1040752 - DOI - PMC - PubMed
1. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci (2001) 38:263–355.10.1080/20014091084227 - DOI - PubMed
1. Wroblewski F, Ladue JS. Serum glutamic pyruvic transaminase in cardiac with hepatic disease. Proc Soc Exp Biol Med (1956) 91:569–71.10.3181/00379727-91-22330 - DOI - PubMed
1. Wroblewski F, Ladue JS. Serum glutamic oxalacetic aminopherase (transaminase) in hepatitis. J Am Med Assoc (1956) 160:1130–4.10.1001/jama.1956.02960480030008a - DOI - PubMed
1. Tonelli M, Curhan G, Pfeffer M, Sacks F, Thadhani R, Melamed ML, et al. Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation (2009) 120:1784–92.10.1161/CIRCULATIONAHA.109.851873 - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Aspartate aminotransferase - risk marker for type-2 diabetes mellitus or red herring?

Affiliations

Aspartate aminotransferase - risk marker for type-2 diabetes mellitus or red herring?

Authors

Affiliations

Figures

Similar articles

Cited by

References

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Figures

Similar articles

Cited by

References

Publication types

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources